GlassScriptPhysician profile
Vani Kotha
NPI 1124233846
$20,364.22
in general payments reported to CMS, 2019-2025
63 companies · $3,091 in 2025
The $3,091 reported for 2025 was more than what 83% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,980 · 2020: $1,941 · 2021: $2,942 · 2022: $2,648 · 2023: $3,614 · 2024: $3,150 · 2025: $3,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,853 · Education: $1.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,852.98 |
| Education | $1.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,879.66 | 2019-2025 | Mounjaro, Lyumjev, Jardiance |
| Astrazeneca Pharmaceuticals LP | $1,627.30 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $1,355.07 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,222.81 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $1,221.04 | 2019-2025 | |
| Abbott Laboratories | $1,160.71 | 2019-2025 | Freestyle Libre 3 |
| Mannkind Corporation | $956.99 | 2019-2025 | Afrezza |
| Xeris Pharmaceuticals, INC. | $828.16 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Amgen INC. | $805.39 | 2019-2025 | Tepezza, Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $766.63 | 2021-2025 | |
| Radius Health, INC. | $716.39 | 2022-2025 | Tymlos |
| Insulet Corporation | $611.15 | 2019-2025 | Omnipod |
| Abbvie INC. | $558.74 | 2019-2025 | |
| Dexcom, INC. | $516.40 | 2019-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $468.84 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System, Intellis Adaptivestim |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $438.56 | 2019-2025 | Korlym |
| Ibsa Pharma INC. | $330.60 | 2019-2025 | Tirosint, Licart, Flector |
| Amneal Pharmaceuticals LLC | $308.89 | 2019-2025 | Unithroid |
| Amarin Pharma, INC. | $302.63 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $300.88 | 2019-2024 | Strensiq |
| Tandem Diabetes Care, INC. | $284.81 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Janssen Pharmaceuticals, INC | $267.76 | 2019-2020 | |
| Becton, Dickinson and Company | $257.00 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $253.88 | 2019-2023 | Steglujan, Steglatro |
| Neurocrine Biosciences, INC. | $213.32 | 2024-2025 | |
| Intuity Medical INC | $207.64 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ascendis Pharma Endocrinology INC | $200.50 | 2023-2025 | Yorvipath |
| Zealand Pharma US, INC. | $180.97 | 2020-2022 | |
| Sequel Med Tech, LLC | $160.41 | 2025 | Twiist |
| Antares Pharma, INC. | $146.18 | 2020-2024 | Xyosted |
| Medtronic Minimed, INC. | $145.67 | 2019-2020 | |
| Pfizer INC. | $128.32 | 2019-2023 | |
| Ultragenyx Pharmaceutical INC. | $124.58 | 2020-2022 | |
| Beta Bionics, INC. | $106.71 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Kyowa Kirin, INC. | $94.40 | 2023-2025 | Crysvita |
| Genzyme Corporation | $90.00 | 2019 | |
| Valeritas, INC. | $69.86 | 2019 | |
| Recordati_rare_diseases_inc. | $67.33 | 2020-2023 | Signifor Lar, Isturisa |
| Tolmar, INC. | $66.74 | 2023 | |
| Avvisto Therapeutics, LLC | $62.11 | 2024-2025 | Cycloset |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.24 | 2023-2024 | Cycloset |
| Rgh Enterprises LLC | $58.99 | 2025 | |
| Horizon Therapeutics Plc | $58.98 | 2021-2023 | Tepezza |
| Shire North American Group INC | $57.35 | 2019 | |
| Amryt Pharma Holdings LTD | $56.34 | 2022-2023 | Mycapssa |
| Lifescan, INC. | $55.70 | 2022-2023 | |
| Amphastar Pharmaceuticals, INC. | $54.98 | 2025 | |
| Vistapharm, INC. | $49.35 | 2021 | |
| Acerus Pharmaceuticals Corporation | $44.19 | 2020-2022 | |
| Cequr Corporation | $38.60 | 2023-2024 | Cequr Simplicity |
| Soleno Therapeutics, INC. | $37.75 | 2025 | Vykat Xr |
| Alvogen INC | $37.14 | 2022-2025 | Teriparatide |
| Clarus Therapeutics INC. | $35.77 | 2021 | |
| Madrigal Pharmaceuticals | $34.42 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $31.05 | 2020 | |
| Althera Pharmaceuticals LLC | $25.26 | 2021 | |
| Chiesi USA, INC. | $23.30 | 2025 | Mycapssa |
| Eisai INC. | $19.31 | 2025 | |
| Halozyme INC | $18.91 | 2023 | |
| Sun Pharmaceutical Industries INC. | $18.61 | 2021 | |
| Astellas Pharma US INC | $17.87 | 2025 | Veozah |
| Ascensia Diabetes Care US INC. | $15.07 | 2024 | |
| Currax Pharmaceuticals LLC | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vani Kotha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.